# Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board
Canonical URL: https://biopharmsignal.com/news/HRMY/harmony-biosciences-strengthens-executive-team-with-new-appointment-and-announces-additions-to-its-board
Ticker: HRMY
Company: Harmony Biosciences
Source: Harmony Biosciences
Published: 2026-04-02 12:05 EST
Original Source URL: https://ir.harmonybiosciences.com
## Summary

Appointments support Harmony’s next phase of growth and long‑term value creation PLYMOUTH MEETING, Pa. --(BUSINESS WIRE)--Apr. 2, 2026-- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the appointment of Peter Anastasiou as Chief Operating Officer and updates to its Board of

## Article Body
Appointments support Harmony’s next phase of growth and long‑term value creation PLYMOUTH MEETING, Pa. --(BUSINESS WIRE)--Apr. 2, 2026-- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the appointment of Peter Anastasiou as Chief Operating Officer and updates to its Board of
## Recent Company News
- 2026-05-07 11:30 EST — [Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities](https://biopharmsignal.com/news/HRMY/harmony-biosciences-reports-q1-financial-results-and-confirms-2026-net-revenue-guidance-of-over-1-billion-reinforces-2026-strategic-priorities) — Source: Harmony Biosciences
- 2026-04-23 12:05 EST — [Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026](https://biopharmsignal.com/news/HRMY/harmony-biosciences-to-report-first-quarter-2026-financial-results-on-may-7-2026) — Source: Harmony Biosciences
- 2026-04-16 12:05 EST — [Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting](https://biopharmsignal.com/news/HRMY/harmony-biosciences-to-present-open-label-extension-data-from-phase-3-argus-trial-at-the-2026-american-academy-of-neurology-annual-meeting) — Source: Harmony Biosciences
- 2026-04-14 12:05 EST — [Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer](https://biopharmsignal.com/news/HRMY/harmony-biosciences-appoints-glenn-reicin-as-chief-financial-officer) — Source: Harmony Biosciences
- 2026-04-02 12:05 EST — [Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board](https://biopharmsignal.com/news/HRMY/harmony-biosciences-strengthens-executive-team-with-new-appointment-and-announces-additions-to-its-board) — Source: Harmony Biosciences
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)